These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 36298831)

  • 21. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.
    Khanam A; Chua JV; Kottilil S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.
    Rehermann B; Thimme R
    Gastroenterology; 2019 Jan; 156(2):369-383. PubMed ID: 30267712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of innate immunity in the immunopathology and treatment of HBV infection.
    Maini MK; Gehring AJ
    J Hepatol; 2016 Apr; 64(1 Suppl):S60-S70. PubMed ID: 27084038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harmonized Autophagy Versus Full-Fledged Hepatitis B Virus: Victorious or Defeated.
    Abdoli A; Nakhaie M; Feizi N; Salimi Jeda A; Ramezani A
    Viral Immunol; 2019 Oct; 32(8):322-334. PubMed ID: 31483214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Interactions between HBV and the Innate Immunity of Hepatocytes.
    Megahed FAK; Zhou X; Sun P
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32151000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel viral and host targets to cure hepatitis B.
    Ko C; Michler T; Protzer U
    Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.
    Wang FS
    World J Gastroenterol; 2003 Apr; 9(4):641-4. PubMed ID: 12679901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
    Ringelhan M; Heikenwalder M; Protzer U
    Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
    Zhang YQ; Guo JS
    World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
    Zhang Z; Zhang JY; Wang LF; Wang FS
    J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.
    Faure-Dupuy S; Lucifora J; Durantel D
    Viruses; 2017 Apr; 9(5):. PubMed ID: 28452930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBV 2021: New therapeutic strategies against an old foe.
    Roca Suarez AA; Testoni B; Zoulim F
    Liver Int; 2021 Jun; 41 Suppl 1():15-23. PubMed ID: 34155787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors.
    Li W; Deng R; Liu S; Wang K; Sun J
    Liver Int; 2020 Oct; 40(10):2316-2325. PubMed ID: 32666675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity related pathogen recognition receptors and chronic hepatitis B infection.
    Nosratabadi R; Alavian SM; Zare-Bidaki M; Shahrokhi VM; Arababadi MK
    Mol Immunol; 2017 Oct; 90():64-73. PubMed ID: 28704708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of hepatitis B virus infection.
    Chisari FV; Isogawa M; Wieland SF
    Pathol Biol (Paris); 2010 Aug; 58(4):258-66. PubMed ID: 20116937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.